@article {813,
	title = {The integrated genomic surveillance system of Andalusia (SIEGA) provides a One Health regional resource connected with the clinic.},
	journal = {Sci Rep},
	volume = {14},
	year = {2024},
	month = {2024 Aug 19},
	pages = {19200},
	abstract = {<p>The One Health approach, recognizing the interconnectedness of human, animal, and environmental health, has gained significance amid emerging zoonotic diseases and antibiotic resistance concerns. This paper aims to demonstrate the utility of a collaborative tool, the SIEGA, for monitoring infectious diseases across domains, fostering a comprehensive understanding of disease dynamics and risk factors, highlighting the pivotal role of One Health surveillance systems. Raw whole-genome sequencing is processed through different species-specific open software that additionally reports the presence of genes associated to anti-microbial resistances and virulence. The SIEGA application is a Laboratory Information Management System, that allows customizing reports, detect transmission chains, and promptly alert on alarming genetic similarities. The SIEGA initiative has successfully accumulated a comprehensive collection of more than 1900 bacterial genomes, including Salmonella enterica, Listeria monocytogenes, Campylobacter jejuni, Escherichia coli, Yersinia enterocolitica and Legionella pneumophila, showcasing its potential in monitoring pathogen transmission, resistance patterns, and virulence factors. SIEGA enables customizable reports and prompt detection of transmission chains, highlighting its contribution to enhancing vigilance and response capabilities. Here we show the potential of genomics in One Health surveillance when supported by an appropriate bioinformatic tool. By facilitating precise disease control strategies and antimicrobial resistance management, SIEGA enhances global health security and reduces the burden of infectious diseases. The integration of health data from humans, animals, and the environment, coupled with advanced genomics, underscores the importance of a holistic One Health approach in mitigating health threats.</p>},
	keywords = {Animals, Drug Resistance, Bacterial, Genome, Bacterial, Genomics, Humans, One Health, Virulence Factors, Whole Genome Sequencing},
	issn = {2045-2322},
	doi = {10.1038/s41598-024-70107-0},
	author = {Casimiro-Soriguer, Carlos S and Perez-Florido, Javier and Robles, Enrique A and Lara, Mar{\'\i}a and Aguado, Andrea and Rodr{\'\i}guez Iglesias, Manuel A and Lepe, Jose A and Garc{\'\i}a, Federico and P{\'e}rez-Alegre, M{\'o}nica and And{\'u}jar, Elo{\'\i}sa and Jim{\'e}nez, Victoria E and Camino, Lola P and Loruso, Nicola and Ameyugo, Ulises and Vazquez, Isabel Mar{\'\i}a and Lozano, Carlota M and Chaves, J Alberto and Dopazo, Joaquin}
}
@article {766,
	title = {Detection of High Level of Co-Infection and the Emergence of Novel SARS CoV-2 Delta-Omicron and Omicron-Omicron Recombinants in the Epidemiological Surveillance of Andalusia.},
	journal = {Int J Mol Sci},
	volume = {24},
	year = {2023},
	month = {2023 Jan 26},
	abstract = {<p>Recombination is an evolutionary strategy to quickly acquire new viral properties inherited from the parental lineages. The systematic survey of the SARS-CoV-2 genome sequences of the Andalusian genomic surveillance strategy has allowed the detection of an unexpectedly high number of co-infections, which constitute the ideal scenario for the emergence of new recombinants. Whole genome sequence of SARS-CoV-2 has been carried out as part of the genomic surveillance programme. Sample sources included the main hospitals in the Andalusia region. In addition to the increase of co-infections and known recombinants, three novel SARS-CoV-2 delta-omicron and omicron-omicron recombinant variants with two break points have been detected. Our observations document an epidemiological scenario in which co-infection and recombination are detected more frequently. Finally, we describe a family case in which co-infection is followed by the detection of a recombinant made from the two co-infecting variants. This increased number of recombinants raises the risk of emergence of recombinant variants with increased transmissibility and pathogenicity.</p>},
	issn = {1422-0067},
	doi = {10.3390/ijms24032419},
	author = {Perez-Florido, Javier and Casimiro-Soriguer, Carlos S and Ortuno, Francisco and Fernandez-Rueda, Jose L and Aguado, Andrea and Lara, Mar{\'\i}a and Riazzo, Cristina and Rodriguez-Iglesias, Manuel A and Camacho-Martinez, Pedro and Merino-Diaz, Laura and Pupo-Ledo, Inmaculada and de Salazar, Adolfo and Vi{\~n}uela, Laura and Fuentes, Ana and Chueca, Natalia and Garc{\'\i}a, Federico and Dopazo, Joaquin and Lepe, Jose A}
}
